William E.: Rho-Kinase Identified as a Novel Target in Post-COVID-19 Vascular Disease
William E. shared a post on LinkedIn about a recent article by Robert A Sykes et al. published in European Heart Journal – Cardiovascular Pharmacotherapy:
“Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.”
Article: Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy
Authors: Robert A Sykes, Karla B Neves, Rhéure Alves-Lopes, Ilaria Caputo, Kirsty Fallon, Nigel B Jamieson, Anna Kamdar, Assya Legrini, Holly Leslie, Alasdair McIntosh, Alex McConnachie, Andrew Morrow, Richard W McFarlane, Kenneth Mangion, John McAbney, Augusto C Montezano, Rhian M Touyz, Colin Wood, Colin Berry
Read the Full Article on European Heart Journal – Cardiovascular Pharmacotherapy
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers